
Octreotide is a synthetic analogue of somatostatin with therapeutic applications in a variety of endocrine and gastrointestinal disorders. We report a patient with acromegaly who developed acute hepatocellular liver injury after receiving two 0.1-mg doses of octreotide. The drug causality was confirmed by rechallenge. To our knowledge this is the second reported case in the literature.
Adenoma, Antineoplastic Agents, Hormonal, Acromegaly, Humans, Female, Pituitary Neoplasms, Chemical and Drug Induced Liver Injury, Middle Aged, Octreotide
Adenoma, Antineoplastic Agents, Hormonal, Acromegaly, Humans, Female, Pituitary Neoplasms, Chemical and Drug Induced Liver Injury, Middle Aged, Octreotide
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 3 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
